Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults [0.03%]
与年轻成人相比，三种mRNA新冠疫苗在老年受试者中产生相似的抗体反应但细胞因子分泌反应较低
Geir Bredholt,Marianne Sævik,Hanne Søyland et al.
Geir Bredholt et al.
Objectives: Booster COVID-19 vaccinations are used to protect the elderly, a group vulnerable to severe disease. We compared humoral and cellular immunity in older versus younger adults up to eight months after administer...
Time-course analysis of antibody and cytokine response after the third SARS-CoV-2 vaccine dose [0.03%]
第三次SARS-CoV-2疫苗接种后的抗体和细胞因子时间推移分析
Hyeon Hwa Kim,Hye Kyung Lee,Lothar Hennighausen et al.
Hyeon Hwa Kim et al.
The widespread administration of an additional dose of the SARS-CoV-2 vaccine has been promoted across adult populations, demonstrating a robust immune response against COVID-19. Longitudinal studies provide crucial data on the durability o...
Social networks and COVID-19 vaccination intention in Dutch middle-aged and older adults in 2020: Insights into individual, interpersonal, community, and societal determinants - The SaNAE study [0.03%]
2020年荷兰中老年人的社交网络与新冠疫苗接种意愿：关于个体、人际、社区和宏观因素的洞见——SaNAE研究
Lisanne C J Steijvers,Céline J A van Bilsen,Stephanie Wagner et al.
Lisanne C J Steijvers et al.
Background: Social networks, our social relationships, influence the spread of infectious diseases and preventive behaviors such as vaccination. Here, we aimed to assess which individual, interpersonal (social network cha...
Persistence of hepatitis B surface antibody until 7 years of age following administration of hexavalent and pentavalent vaccines in children at 2, 4, 6, and 18 months [0.03%]
2月龄、4月龄、6月龄和18月龄接种六联及五价疫苗儿童乙型肝炎表面抗体7年人群免疫持久性分析
Nasamon Wanlapakorn,Nasiri Sarawanangkoor,Donchida Srimuan et al.
Nasamon Wanlapakorn et al.
Thailand incorporated the hepatitis B (HepB) vaccine into the infant combination vaccine known as pentavalent wP-containing vaccines (DTwP-HB-Hib) and hexavalent aP-containing vaccines (DTaP-IPV-HB-Hib). We followed healthy children from th...
Caregiver acceptance of human papillomavirus vaccine for their female children in Chileka, Blantyre, Malawi [0.03%]
马拉维布兰太尔卡雷吉韦的人乳头瘤病毒疫苗接种接受度调查
Akim N Bwanali,Petro Liundi,Adriano F Lubanga et al.
Akim N Bwanali et al.
Introduction: Malawi is one of the countries enduring an enormous burden of cervical cancer. Human Papillomavirus (HPV) vaccination offers a feasible and effective tool for reducing the burden. Such a prospect however, is...
Impact of Bacille Calmette-Guérin vaccination on the therapeutic schedule of infantile epileptic spasms syndrome: A 25-year Japanese single-center survey [0.03%]
卡介苗接种对婴儿痉挛症治疗时间的影响：日本单中心25年调查研究
Hikaru Kobayashi,Hirofumi Inoue,Takeshi Matsushige et al.
Hikaru Kobayashi et al.
Adrenocorticotropic hormone (ACTH) therapy is effective for infantile epileptic spasms syndrome (IESS) but can induce immunosuppression. In Japan, Bacille Calmette-Guérin (BCG) vaccination, modified in 2013 to reduce osteitis/osteomyelitis...
Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development [0.03%]
一种改进的肠道病毒71型和柯萨奇病毒A16型二价疫苗生产方法：无血清HEK293A细胞悬浮培养体系中表达重组CVA16病毒颗粒
Yi-An Chen,Yu-Sheng Shen,Chih-Yeu Fang et al.
Yi-An Chen et al.
Coxsackievirus A16 (CVA16) is one of the primary pathogens that causes hand, foot, and mouth disease (HFMD) in young children. In previous studies, CVA16 vaccine development has encountered several challenges, such as inefficient replicatio...
Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019-2020 targeted preventative mass campaigns [0.03%]
刚果民主共和国戈马市2022年口服霍乱疫苗接种覆盖率——2019—2020年定点预防群体接种之后的效果
Emily Briskin,Stéphane Hans Bateyi Mustafa,Rachel Mahamba et al.
Emily Briskin et al.
Background: In 2019-2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success...
Characteristics of inpatient and outpatient respiratory syncytial virus mortality in Gavi-eligible countries [0.03%]
关于GAVI资格国家住院和门诊呼吸道合胞病毒死亡率的特点
Joukje E Willemsen,Femke S Vernooij,Farina L Shaaban et al.
Joukje E Willemsen et al.
The current understanding of the RSV-related mortality age distribution in low- and lower-middle-income countries (LMICs) relies on a limited number of disease incidence studies reporting wide age bands, and lacking specificity to Gavi-elig...
Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey [0.03%]
福岛疫苗社区调查历史队列研究中的新冠疫苗加强针后5个月的体液和细胞免疫反应动力学：在峰值免疫力阶段按免疫反应分组分析
Yurie Kobashi,Takeshi Kawamura,Yuzo Shimazu et al.
Yurie Kobashi et al.
Background: Understanding the waning of immunity after booster vaccinations is important to identify which immune-low populations should be prioritized. M...